4//SEC Filing
Appelhans Dannielle 4
Accession 0001179110-21-008515
CIK 0001709401other
Filed
Aug 31, 8:00 PM ET
Accepted
Sep 1, 8:12 PM ET
Size
7.6 KB
Accession
0001179110-21-008515
Insider Transaction Report
Form 4
Appelhans Dannielle
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-08-31+150,000→ 150,000 totalExercise: $21.72Exp: 2031-08-30→ Common Stock (150,000 underlying) - Award
Restricted Stock Units
2021-08-31+50,000→ 50,000 total→ Common Stock (50,000 underlying)
Footnotes (3)
- [F1]25% of this option shall vest on August 9, 2022, then in 12 equal quarterly installments thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F3]The shares underlying the restricted stock units will vest in four equal annual installments beginning on August 9, 2022.
Documents
Issuer
Rubius Therapeutics, Inc.
CIK 0001709401
Entity typeother
Related Parties
1- filerCIK 0001874962
Filing Metadata
- Form type
- 4
- Filed
- Aug 31, 8:00 PM ET
- Accepted
- Sep 1, 8:12 PM ET
- Size
- 7.6 KB